Search results
Results from the WOW.Com Content Network
The consensus is to reduce dosage gradually over several weeks, e.g. 4 or more weeks for diazepam doses over 30 mg/day, [1] with the rate determined by the person's ability to tolerate symptoms. [120] The recommended reduction rates range from 50% of the initial dose every week or so, [121] to 10–25% of the daily dose every 2 weeks. [120]
Dr Adrian James, president of the Royal College of Psychiatrists, said: “We know that antidepressants can save lives, and most people will not need to take them for more than six to 12 months ...
Examples (and ICD-10 code) of withdrawal syndrome include: F10.3 alcohol withdrawal syndrome (which can lead to delirium tremens) F11.3 Opioid withdrawal, including methadone withdrawal [9] F12.3 cannabis withdrawal; F13.3 benzodiazepine withdrawal; F14.3 cocaine withdrawal; F15.3 caffeine withdrawal; F17.3 nicotine withdrawal
Olanzapine, sold under the brand name Zyprexa among others, is an atypical antipsychotic primarily used to treat schizophrenia and bipolar disorder. [13] It is also sometimes used off-label for treatment of chemotherapy-induced nausea and vomiting [14] and as an appetite stimulant. [15]
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress.. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication.
New research suggests that slowly tapering off GLP-1 drugs like Ozempic and Wegovy while adopting lifestyle changes may help prevent rebound weight gain.
This is a general list of long-term side effects associated with Antipsychotic (neuroleptic) medication.. Many patients will not develop these side effects, although there is still a significant possibility of risks associated with Antipsychotic usage.
Olanzapine/fluoxetine was approved by the U.S. Food and Drug Administration (FDA) to treat the depressive episodes of bipolar I disorder in 2003. [1] In 2009, it was granted approval for the treatment of treatment-resistant depression.